The @entity1 was a 51-year-old @entity1 who had been prescribed @entity2049 for right third-branch trigeminal @entity9 . He had stopped taking the medication after the @entity9 resolved. When the @entity9 recurred, he resumed medication, and about 1 month later he developed @entity221 , @entity1295 , cervical @entity3329 , generalized skin flushing, @entity4 and @entity24423 , and was admitted to Ichikawa General Hospital, Tokyo Dental College. Oral findings showed @entity14705 . Routine laboratory examination revealed @entity491 and @entity409 . Human herpesvirus 6 antibody titer remarkably increased during development of @entity203 . These findings led to a diagnosis of @entity56 . @entity2049 was discontinued, and @entity617 (30 mg/day) was started and tapered based on improvement of symptoms. Because skin symptoms recurred after he was discharged 15 days after admission, the dose of @entity617 was increased and the symptoms finally disappeared. The @entity1 has experienced no further recurrence.

A case of @entity56 due to XXXX .

@entity1 :: ('9606', 'Species') :: ['patient', 'man'] @entity3329 :: ('MESH:D008206', 'Disease') :: ['lymphadenopathy'] @entity14705 :: ('MESH:D007967', 'Disease') :: ['reddening and erosion of the buccal mucosa'] @entity4 :: ('MESH:D004487', 'Disease') :: ['facial edema'] @entity491 :: ('MESH:D007964', 'Disease') :: ['leukocytosis'] @entity409 :: ('MESH:D008107', 'Disease') :: ['hepatic dysfunction'] @entity1295 :: ('MESH:D005221', 'Disease') :: ['fatigue'] @entity203 :: ('MESH:D003875', 'Disease') :: ['eruptions'] @entity2049 :: ('MESH:D002220', 'Chemical') :: ['Carbamazepine', 'carbamazepine'] @entity56 :: ('MESH:D004342', 'Disease') :: ['drug-induced hypersensitivity syndrome'] @entity24423 :: ('MESH:D019557', 'Disease') :: ['perioral vesicles'] @entity221 :: ('MESH:D005334', 'Disease') :: ['fever'] @entity9 :: ('MESH:D009437', 'Disease') :: ['neuralgia'] @entity617 :: ('MESH:D011239', 'Chemical') :: ['prednisolone']
@entity2049 :: (MESH:D002220,Chemical) :: ['carbamazepine']
